Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision Medicine in Patients with Differential Diabetic Phenotypes: Novel Opportunities from Network Medicine.

Current diabetes reviews - 1 Jan 2022

Napoli Claudio, Benincasa Giuditta, Ellahham Samer

Abstract excerpt

INTRODUCTION: Diabetes mellitus (DM) comprises differential clinical phenotypes ranging from rare monogenic to common polygenic forms, such as type 1 (T1DM), type 2 (T2DM), and gestational diabetes, which are associated with cardiovascular complications. Also, the high- -risk prediabetic state is rising worldwide, suggesting the urgent need for early personalized strategies to prevent and treat a hyperglycemic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Diabetes Mellitus, Type 1
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Phenotype

Share to Precision Medicine

Source

Identifiers

PMID: 34951369
DOI: 10.2174/1573399818666211222164400

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision Medicine in Patients with Differential Diabetic Phenotypes: Novel Opportunities from Network Medicine.PMID 34951369Read ↗

Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integrationSemantic proximity Read ↗

Multi-omics regulatory networks reveal the key driver genes in the development of type 2 diabetesSemantic proximity Read ↗

Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.Semantic proximity Read ↗

Identification of key genes, biological functions, and pathways of empagliflozin by network pharmacology and its significance in the treatment of type 2 diabetes mellitusSemantic proximity Read ↗

Elucidating the Type 2 Diabetes Regulatory Network: Identification of EGFR as a Key Hub and Novel Drug CandidatesSemantic proximity Read ↗

Potential Biomarkers of Diabetic Kidney Disease Based on Weighted Gene Co-expression Network AnalysisSemantic proximity Read ↗

A Pathway and Network Oriented Approach to Enlighten Molecular Mechanisms of Type 2 Diabetes Using Multiple Association StudiesSemantic proximity Read ↗

Precision medicine in type 2 diabetesSemantic proximity Read ↗

Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertensionSemantic proximity Read ↗

Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.Semantic proximity Read ↗

Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancerSemantic proximity Read ↗

Decoding Diabetes Biomarkers and Related Molecular Mechanisms by Using Machine Learning, Text Mining, and Gene Expression AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.